Oral Anticoagulation Therapy in Children: Successfully Controlled by Self-Management
Authors:
- Thomas Decker ChristensenTCThomas Decker Christensen
- Niels Trolle AndersenNANiels Trolle Andersen
- Ole Kromann HansenOHOle Kromann Hansen
- Vibeke Elisabeth HjortdalVHVibeke Elisabeth Hjortdal
- J. Michael HasenkamJHJ. Michael Hasenkam
- 1 August 2004
- journal article
- clinical trial
- Published by IMR Press in The Heart Surgery Forum
- Vol. 7 (4) , E321-E325
Abstract
Children with congenital heart disease and who are on oral anticoagulation therapy present special challenges due to, for example, rapid fluctuations in international normalized ratio (INR) values, interruption in daily life due to frequent hospital/doctor visits, and difficulties and pain to the child in the performance of venipuncture. We hypothesize that oral anticoagulation therapy can be successfully controlled by self-management for this subset of patients. The aim of this study was to assess the treatment quality of self-managed oral anticoagulation therapy as the proportion of time within the therapeutic INR target range in children with congenital heart disease. Children (N = 22) with a mean age of 10.6 years (range, 1.8-18.6 years) and their parents were trained in home blood analysis of INR and in coumarin dosage adjustment. After training, the children were monitored by weekly INR measurements. The therapeutic range in target INR values was +/-0.5. The indications for initiating oral anticoagulation therapy were the presence of a mechanical heart valve (n = 16) and total cavopulmonary connection (n = 6). The children had no physical restrictions. The mean observation time was 3.6 years (range, 0.9-5.8 years), and the total number of patient-years was 75.4. The patients were within the therapeutic INR target range for a median of 73.1% (range, 30.3%-91.0%) of the observation time. Two children died for reasons not related to the oral anticoagulation therapy. None of the patients experienced thromboembolic or bleeding complications requiring doctor intervention. Self-management of oral anticoagulation therapy is safe and provides a good quality of treatment for selected children with congenital heart disease.Keywords
This publication has 19 references indexed in Scilit:
- International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?The Annals of Thoracic Surgery, 2001
- Self-management of oral anticoagulation in children with congenital heart diseaseCardiology in the Young, 2001
- Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparisonThe Lancet, 2000
- Capillary Whole Blood Monitoring of Oral Anticoagulants in Children in Outpatient Clinics and the Home SettingPediatric Cardiology, 2000
- Mitral-valve replacement in children under 6 years of ageEuropean Journal of Cardio-Thoracic Surgery, 2000
- Self management of oral anticoagulant therapy after heart valve replacementEuropean Journal of Cardio-Thoracic Surgery, 1997
- Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-managementAmerican Heart Journal, 1996
- Antithrombotic Therapy in ChildrenChest, 1995
- Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitorThe Journal of Pediatrics, 1995
- Valve replacement in children less than 5 years of ageJACC, 1986